HITIQ Ltd
Research HITIQ Ltd (HIQ) on Bullrun: market cap AUD 4.54M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHIQ
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 4.54M
- Financial periodFY2025
- RevenueAUD 673.25K
- Revenue growth-40.0%
- Net income-AUD 7.21M
- Free cash flow-AUD 4.68M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 4.54M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 673.25K | -AUD 7.21M | -AUD 4.68M | 100.0% | -0.02 | AUD 990.96K | AUD 5.66M | -AUD 4.02M |
| FY2024 | AUD 1.12M | -AUD 3.20M | -AUD 4.23M | 100.0% | -0.01 | AUD 584.02K | AUD 3.20M | -AUD 1.47M |
| FY2023 | AUD 774.26K | -AUD 5.04M | -AUD 4.57M | 100.0% | -0.02 | AUD 1.98M | AUD 297.40K | -AUD 46.86K |
| FY2022 | AUD 619.02K | -AUD 6.95M | -AUD 6.57M | 100.0% | -0.04 | AUD 2.94M | AUD 2.16M | AUD 1.17M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 4.54M | n/a | n/a | n/a |
About HITIQ Ltd
HITIQ Limited, together with its subsidiaries, develops and commercializes concussion management technology in Oceania. The company offers smart mouthguards and software for sports, clinical, and research applications. It also provides PROTEQT, a smart mouthguard with sensor technology to detect, assess, and manage potential head impacts, as well as a concussion management app, replacement parts, and charger kits;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HITIQ Ltd's market cap?
HITIQ Ltd's market capitalization is AUD 4.54M.
What does HITIQ Ltd do?
HITIQ Limited, together with its subsidiaries, develops and commercializes concussion management technology in Oceania. The company offers smart mouthguards and software for sports, clinical, and research applications.